These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5631692)

  • 1. [The influence of diethyldithiocarbamate on cerebral catecholamine, spontaneous activity and L-DOPA hyperactivity].
    Aigner A; Hornykiewicz O; Lisch HJ; Springer A
    Med Pharmacol Exp Int J Exp Med; 1967; 17(6):576-85. PubMed ID: 5631692
    [No Abstract]   [Full Text] [Related]  

  • 2. L-DOPA attenuates hyperactivity of Roborovskii hamsters.
    Kabuki Y; Shigemi K; Hamasu K; Furuse M
    Behav Pharmacol; 2009 May; 20(3):260-4. PubMed ID: 19404194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: Effect of acute and chronic treatment with L-dopa on catecholamine turnover.
    Yamanaka Y; Kono S
    Jpn J Pharmacol; 1974; 24(0):s:24. PubMed ID: 4545736
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancement by 6-hydroxydopamine of the effects of DOPA upon the motor activity of rats.
    Schoenfeld RI; Uretsky NJ
    J Pharmacol Exp Ther; 1973 Sep; 186(3):616-24. PubMed ID: 4728340
    [No Abstract]   [Full Text] [Related]  

  • 5. L-DOPA: effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice.
    Everett GM; Borcherding JW
    Science; 1970 May; 168(3933):847-50. PubMed ID: 5444060
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of L-DOPA on the EEG and brain amines of unrestrained rats.
    Thut PD; Rech RH
    Exp Neurol; 1972 Apr; 35(1):13-29. PubMed ID: 5026410
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of L-DOPA on S-adenosylmethionine levels and norepinephrine metabolism in rat brain.
    Wurtman RJ
    Adv Biochem Psychopharmacol; 1972; 6():241-6. PubMed ID: 5055596
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison between the effect of L-dopa and its methylated ester on cerebral dopamine and noradrenaline of rats exposed to oxypertin].
    Van den Driessche J; Sado M; Linée P; Lacroix P; Le Clec'h G; Delamaire J; Patay M
    C R Seances Soc Biol Fil; 1973; 167(5):754-9. PubMed ID: 4799139
    [No Abstract]   [Full Text] [Related]  

  • 9. Regional effects of L-dihydroxyphenylalanine (L-dopa) on norepinephrine metabolism in rat brain.
    Romero JA; Chalmers JP; Cottman K; Lytle LD; Wurtman RJ
    J Pharmacol Exp Ther; 1972 Feb; 180(2):277-85. PubMed ID: 5010674
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of catecholamine synthesis inhibition on ethanol narcosis in mice.
    Blum K; Merritt JH; Wallace JE; Owen R; Hahn JW; Geller I
    Curr Ther Res Clin Exp; 1972 Jun; 14(6):324-9. PubMed ID: 4625804
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of L-DOPA on aggressive behavior and central monoaminergic activity in the lizard Anolis carolinensis, using a new method for drug delivery.
    Höglund E; Korzan WJ; Watt MJ; Forster GL; Summers TR; Johannessen HF; Renner KJ; Summers CH
    Behav Brain Res; 2005 Jan; 156(1):53-64. PubMed ID: 15474650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Selective concentration of dopamine in the parenchyma of the rat brain].
    Constantinidis J; Bartholini G; Tissot R; Pletscher A
    Helv Physiol Pharmacol Acta; 1967; 25(4):CR411+. PubMed ID: 5586884
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of DOPA on the visual-evoked potentials in rabbit and on mouse motor behavior following inhibition of dopamine-beta-hydroxylase.
    Sabelli HC; Giardina WJ; Myles SB; Vazquez AJ
    Arzneimittelforschung; 1974 Mar; 24(3):333-7. PubMed ID: 4407412
    [No Abstract]   [Full Text] [Related]  

  • 14. L-dopa, dopamine, and hypomania.
    Murphy DL; Goodwin FK; Brodie HK; Bunney WE
    Am J Psychiatry; 1973 Jan; 130(1):79-82. PubMed ID: 4682751
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of 6-hydroxydopa and 5,6-dihydroxytryptophan treatment on spontaneous motor activity and brain monoamines in mice.
    Segawa T; Sakamoto K; Naitoh F
    Jpn J Pharmacol; 1975 Oct; 25(5):612-5. PubMed ID: 1082954
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of L-DOPA analogues in Sidman avoidance performance in mice.
    Thut PD
    Life Sci; 1977 Aug; 21(3):423-31. PubMed ID: 895374
    [No Abstract]   [Full Text] [Related]  

  • 17. The depression of sensitivity to noradrenaline caused by L-dopa.
    Eden E; Nasmyth PA
    J Physiol; 1973 Apr; 230(1):7P-8P. PubMed ID: 4702454
    [No Abstract]   [Full Text] [Related]  

  • 18. Behavioural and biochemical interaction between caffeine and L-dopa.
    Strömberg U; Waldeck B
    J Pharm Pharmacol; 1973 Apr; 25(4):302-8. PubMed ID: 4146682
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence for the biological activity of the deaminated metabolites of the adrenergic amines.
    Giardina WJ; Sabelli HC
    Biol Psychiatry; 1974 Aug; 9(1):11-23. PubMed ID: 4457115
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: The role of brain dopamine in the hyperactivity syndrome produced in rats after administration of L-tryptophan and a monoamine oxidase inhibitor.
    Grahame-Smith DG; Green AR
    Br J Pharmacol; 1974 Mar; 50(3):442P-443P. PubMed ID: 4853875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.